12/12/2019ChP Commission Solicits Comments on the draft of “Naming Principles f...

12/12/2019Eli Lilly's Verzenio and Amgen's Blincyto To Be Granted Priority Revie...

12/12/2019Upcoming Event: International Conference on Biosimilars and Biologics

12/12/2019Astrazeneca Rounds Out Stellar China Year - And Beats Roche To The Pun...

12/12/2019Numab and 3SBio's Subsidiary Form Partnership to Develop Novel Multi-s...

12/12/2019NMPA Issues the Guidelines for Aluminum Adjuvant in Preventative Vacci...

12/12/2019AstraZeneca Granted Chinese Approval of Imfinziin for Unresectable Sta...

12/11/2019Avantor Opens Center in Shanghai to Boost Biopharma Innovation in Chin...

12/11/2019China's Cancer Patients Hit by New Law on Experimental Drug Treatments...

12/11/2019Harbin Pharmaceutical Group Poised to Take Over Ailing GNC

12/11/2019Private Investigator Couple Sue GSK for Misleading Work in China

12/10/2019National Drug Usage Monitoring Platform Becomes Operational

12/10/2019SAMR Solicits Public Comments on the Provisions for Registration of Dr...

12/10/2019CStone's anti-PD-L1 antibody Demonstrates Promising Antitumor Activity

12/10/2019China Cuts Prices For 70 More Drugs After Talks with Pharmaceutical Fi...

12/9/2019PingAn Good Doctor and Merck Sign Agreement to Explore Integrated Heal...

12/9/2019Samsung Bioepis Approved to Initiate Phase 3 Trial of Trastuzumab Bios...

12/9/2019Joinn Bio Raises $60M in Round A Financing

12/6/2019NHSA Issues New Policy for Drug Price Regulation

12/6/2019Recent Executive Moves

12/6/2019Innovent Announces First Patient Dosed in Phase I Trial of Anti-LAG-3 ...

12/5/2019Amgen's IND for Osteoporosis Drug Romosozumab Approved in China

12/5/2019XiAn Janssen's Application for 2nd Indication of Erleada Accepted in C...

12/5/2019Interpace Bio Expands Strategic Partnership with Genecast in China

12/5/2019AstraZeneca-Merck Lynparza Approved in China for Ovarian Cancer

12/4/2019Bio-Thera's IND for Biosimilar of Stelara (Ustekinumab) Approved in Ch...

12/4/2019Yaobili Set to Change China's Pharmaceutical Industry with New Model

12/4/2019Additional Indication for Lenvima (Lenvatinib) For Differentiated Thyr...

12/3/2019Why Chinese Biotech Companies Are Not For Faint-Hearted Investors

12/3/2019New Round of Negotiation for NRDL Access Begins as Big Pharma Bosses L...

Page:282/801 Total number of articles:24010: [First][<<] [280] [281] [282] [283] [284] [>>] [End]